Ezetimibe/Simvastatin: A Guide to its Clinical Use in Hypercholesterolemia

被引：0
作者：
Katherine A. Lyseng-Williamson
机构：
[1] Adis,
[2] a Wolters Kluwer Business,undefined
来源：
American Journal of Cardiovascular Drugs | 2012年 / 12卷
关键词：
Chronic Kidney Disease; Statin; Simvastatin; Atorvastatin; Statin Therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Ezetimibe/simvastatin therapy combines two lipid-lowering compounds with complementary mechanisms of action, thereby blocking the two sources of plasma cholesterol and improving lipid profiles. Ezetimibe/simvastatin is an effective and generally well tolerated adjunct to dietary therapy for markedly reducing lowdensity lipoprotein cholesterol (LDL-C) levels and improving other lipid parameters across diverse patient populations. Dual treatment with ezetimibe/simvastatin is more effective than monotherapy with an HMG-CoA reductase inhibitor (statin), and the addition of ezetimibe to current statin therapy is more effective than doubling the statin dose.
引用
收藏
页码：49 / 56
页数：7
相关论文
共 50 条
[21]   Clinical Efficacy and Tolerability of Ezetimibe in Combination With Atorvastatin in Japanese Patients With Hypercholesterolemia-Ezetimibe Phase IV Randomized Controlled Trial in Patients With Hypercholesterolemia [J].
Teramoto, Tamio ;
Sawada, Teruo ;
Iwamoto, Kazuya ;
Daida, Hiroyuki .
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2012, 73 (1-2) :16-40
[22]   Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia [J].
Katsiki, N. ;
Athyros, V. G. ;
Karagiannis, A. ;
Mikhailidis, D. P. .
INTERNATIONAL ANGIOLOGY, 2011, 30 (03) :295-295
[23]   Long-term (48-week) safety of ezetimibe 10 mg/day coadministered with simvastatin compared to simvastatin alone in patients with primary hypercholesterolemia [J].
Bays, Harold ;
Sapre, Aditi ;
Taggart, William ;
Liu, Ji ;
Capece, Rachel ;
Tershakovec, Andrew .
CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (10) :2953-2966
[24]   The ezetimibe controversy - can this be resolved by comparing the clinical trials with simvastatin and ezetimibe alone and together? [J].
Doggrell, Sheila A. .
EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (10) :1469-1480
[25]   Ezetimibe: an update on its clinical usefulness in specific patient groups [J].
Hammersley, Daniel ;
Signy, Mark .
THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2017, 8 (01) :4-11
[26]   Pleiotropic effects of ezetimibe/simvastatin vs. high dose simvastatin [J].
Pesaro, Antonio Eduardo P. ;
Serrano, Carlos V., Jr. ;
Fernandes, Juliano L. ;
Cavalcanti, Alexandre B. ;
Campos, Alexandre H. ;
Martins, Herlon S. ;
Maranhao, Raul C. ;
de Lemos, James A. ;
Souza, Heraldo P. ;
Nicolau, Jose C. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 158 (03) :400-404
[27]   Efficacy and safety of coad ministration of ezetimibe and simvastatin in African-American patients with primary hypercholesterolemia [J].
Rodney, Roxanne A. ;
Sugimoto, Daniel ;
Wagman, Bernard ;
Zieve, Franklin ;
Kerzner, Boris ;
Strony, John ;
Yang, Bo ;
Suresh, Ramachandran ;
Veltri, Enrico .
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2006, 98 (05) :772-778
[28]   Effects of simvastatin, atorvastatin, ezetimibe, and ezetimibe plus simvastatin combination on the inflammatory process and on the liver metabolic changes of arthritic rats [J].
Bracht, Livia ;
Barbosa, Carmem Patricia ;
Caparroz-Assef, Silvana Martins ;
Nakamura Cuman, Roberto Kenji ;
Ishii-Iwamoto, Emy Luiza ;
Bracht, Adelar ;
Bersani-Amado, Ciomar Aparecida .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 (06) :722-734
[29]   Effects of ezetimibe/simvastatin combination on metabolic parameters [J].
Filippatos, Theodosios D. ;
Elisaf, Moses S. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 202 :273-274
[30]   Ezetimibe Plus Moderate-dose Simvastatin After Acute Coronary Syndrome: What Are We IMPROVEing On? [J].
DiNicolantonio, James J. ;
Chatterjee, Subhankar ;
Lavie, Carl J. ;
Bangalore, Sripal ;
O'Keefe, James H. .
AMERICAN JOURNAL OF MEDICINE, 2015, 128 (08) :914.e1-914.e4
12345